This finding is in agreement with a previous study which shows that HCC cells treated with metformin exhibit significantly reduced cell proliferative, migratory and invasive capacities, during which alternative splicing of LGR4 plays a central role (30). Here, LGR4 is linked to hepatocellular carcinoma.